Literature DB >> 9790496

STAT3 activation accompanies keratinocyte differentiation.

P J Hauser1, D Agrawal, J Hackney, W J Pledger.   

Abstract

The signal transducers and activators of transcription (STAT) family of transcription factors has been demonstrated to play key roles in a variety of cell types under conditions that promote differentiation or cell cycle exit. We report our studies of primary murine keratinocytes in which we demonstrate activation of STAT3 during growth arrest and differentiation. In adherent cells, STAT3-specific DNA binding activity was detected in quiescent cultures, down-regulated upon mitogenic stimulation, and found to reaccumulate as cells reentered quiescence. Suspension culturing of proliferating keratinocytes, which induces differentiation, also resulted in induction of STAT3 activity. Furthermore, induction of STAT3 after suspension culturing did not occur in MK cells, an immortalized murine keratinocyte cell line that does not undergo differentiation. Because STAT3 activation in these cells corresponded tightly with the growth status, we examined whether there was a relationship between the cell cycle machinery and STAT3 activation by inhibiting p27kip1 accumulation, which is observed during growth arrest, with antisense oligonucleotides and by using keratinocytes lacking functional p27kip1. In both cases, there was a loss of STAT3 activation and a concomitant delay in terminal cell cycle withdrawal and in the expression of the differentiation specific marker, keratin 1. Thus, in addition to controlling transcription mediated through E2F, our data demonstrate that alterations in the cell cycle machinery are required for appropriate up-regulation of STAT3 activity that occurs during keratinocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790496

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  10 in total

1.  Immunolocalisation of the janus kinases (JAK)--signal transducers and activators of transcription (STAT) pathway in human epidermis.

Authors:  H Nishio; K Matsui; H Tsuji; A Tamura; K Suzuki
Journal:  J Anat       Date:  2001-05       Impact factor: 2.610

Review 2.  STAT signaling in the pathogenesis and treatment of cancer.

Authors:  D A Frank
Journal:  Mol Med       Date:  1999-07       Impact factor: 6.354

3.  Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein.

Authors:  J Turkson; T Bowman; J Adnane; Y Zhang; J Y Djeu; M Sekharam; D A Frank; L B Holzman; J Wu; S Sebti; R Jove
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 4.  STAT3 regulation of glioblastoma pathogenesis.

Authors:  Núria de la Iglesia; Sidharth V Puram; Azad Bonni
Journal:  Curr Mol Med       Date:  2009-06       Impact factor: 2.222

5.  Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes.

Authors:  Chi Tarn; Lin Zou; Ronald L Hullinger; Ourania M Andrisani
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Requirement of STAT3 activation for differentiation of mucosal stratified squamous epithelium.

Authors:  Rong Wu; Shishinn Sun; Bettie M Steinberg
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

7.  Cell confluency-induced Stat3 activation regulates NHE3 expression by recruiting Sp1 and Sp3 to the proximal NHE3 promoter region during epithelial dome formation.

Authors:  Hsiao-Wen Su; Shainn-Wei Wang; Fayez K Ghishan; Pawel R Kiela; Ming-Jer Tang
Journal:  Am J Physiol Cell Physiol       Date:  2008-10-22       Impact factor: 4.249

8.  STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications.

Authors:  Jennifer E Kim; Mira Patel; Jacob Ruzevick; Christopher M Jackson; Michael Lim
Journal:  Cancers (Basel)       Date:  2014-02-10       Impact factor: 6.639

9.  Expression of JAK3, STAT2, STAT4, and STAT6 in pemphigus vulgaris.

Authors:  K Juczynska; A Wozniacka; E Waszczykowska; M Danilewicz; M Wągrowska-Danilewicz; Agnieszka Zebrowska
Journal:  Immunol Res       Date:  2020-04       Impact factor: 2.829

10.  Human skin biomarkers relationship to response to treatment with tyrosine kinase inhibitors in advanced EGFR-mutated lung adenocarcinoma.

Authors:  Anahí Castañeda-Zárraga; Jerónimo Rafael Rodríguez-Cid; Rodrigo Rafael Flores-Mariñelarena; Héctor Trinidad-Bibiano; José Fabián Martínez-Herrera; Carla Paola Sánchez-Ríos; Valeria Michelle Fernández-Garibay; Jorge Arturo Alatorre-Alexander; Luis Martínez-Barrera; Patricio Javier Santillán-Doherty; María Elisa Vega-Memije
Journal:  Thorac Cancer       Date:  2020-10-05       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.